finance.yahoo.comDar Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC9 months ago
finance.yahoo.comDar Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Safety Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%11 months ago
finance.yahoo.comDar Bioscience to Host Second Quarter 2024 Financial Results and Company Update Conference Call and Webcast on August 12, 202412 months ago
finance.yahoo.comDar Bioscience Regains Compliance with Nasdaq Minimum Bid Price Ruleabout 1 year ago
finance.yahoo.comBiotech Executive Lisa Walters-Hoffert Joins Kiora Pharmaceuticals' Board of Directorsabout 1 year ago
finance.yahoo.comDar Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results of Topical Sildenafil Cream, 3.6% for the Treatment of Female Sexual Arousal Disorderabout 1 year ago